Premature Coronary Artery Disease in Women - Risk Factors and Prognosis
PRECADIW
1 other identifier
observational
670
1 country
1
Brief Summary
Cardiovascular risk in women is systematically underestimated by both - society and physicians. Women younger than 50 years of age with acute coronary syndrome have 2x higher mortality compared with age-matched men. A number of common vascular-disease-related conditions are more frequent in women than in men. Women develop a more severe or different form of vascular disease then men. Variability of onset, relative risk, and the synergy of traditional and novel risk factors creates a challenge to physicians possibly resulting in suboptimal management and disregard in women presenting with angina symptoms. During last 10 years the rise in coronary artery disease (CAD) prevalence in younger women is observed. Emerging data suggest a unique risk profile in women (hypoestrogenemia with adverse effects of a protracted dysmetabolic state). The risk factors assessment and the risk factors profiles in women that are associated with CAD may be different than in men and thus merit reassessment. Purpose The primary objective of this study is to determine characteristics and prognosis of women with premature coronary artery disease and to evaluate the extent of atherosclerosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 15, 2007
CompletedFirst Posted
Study publicly available on registry
October 16, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedJanuary 18, 2012
January 1, 2012
5.2 years
October 15, 2007
January 16, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Comparison of clinical characteristics between study group and matched controls
1-year (short-term), 4-year (long-term)
Association of clinical factors to extent and advance of atherosclerosis
1-year (short-term), 4-year (long-term)
Predictive role of clinical factors on prognosis in terms of MACE
1-year (short-term), 4-year (long-term)
Secondary Outcomes (2)
Predictive role of clinical factors on prognosis in terms of Vascular Events
1-year, 2-year, 3-year, 4-year
Predictive role of clinical factors on prognosis in terms of components of Vascular Events and total mortality
1-year, 2-year, 3-year, 4-year
Study Arms (2)
1
323 women with established coronary artery disease before 55 year of age
2
347 clinically healthy, age matched women selected from the National Health Survey WOBASZ study with negative history of CVD or negative exertional chest pain.
Eligibility Criteria
Cases: Consecutive women with onset of evident CAD before 55 years of age (admitted to coronary angiography because of acute coronary syndrome, stable angina or revascularization procedure Controls: age-matched healthy women selected from participants examined between 2004-2006 in the National Health Survey - WOBASZ study with negative history of exertional chest pain, angina, hospitalization of revascularization procedures or coronary treatment
You may qualify if:
- Patients: Consecutive women with onset of evident CAD before 55 years of age (admitted to coronary angiography because of acute coronary syndrome, stable angina or revascularization procedure)
- agreement to participate the study
- Controls : age-matched healthy women selected from participants examined between 2004-2006 in the National Health Survey - WOBASZ study with negative history of exertional chest pain, angina, hospitalization of revascularization procedures or coronary treatment.
You may not qualify if:
- inability to give informed consent death before discharge during the index hospitalization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Cardiology,
Warsaw, 04-628, Poland
Related Publications (2)
Lubiszewska B, Kruk M, Broda G, Ksiezycka E, Piotrowski W, Kurjata P, Zielinski T, Ploski R. The impact of early menopause on risk of coronary artery disease (PREmature Coronary Artery Disease In Women--PRECADIW case-control study). Eur J Prev Cardiol. 2012 Feb;19(1):95-101. doi: 10.1177/1741826710394269. Epub 2011 Feb 21.
PMID: 21450613RESULTLubiszewska B, Skora E, Kruk M, Broda G, Ksiezycka E, Kurjata P, Zielinski T, Ploski R. Prevalence of classical risk factors in Polish women with premature coronary artery disease. Kardiol Pol. 2010 Sep;68(9):1032-7.
PMID: 20859896RESULT
Biospecimen
whole blood, serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara M Lubiszewska
National Institute of Cardiology, Warsaw, Poland
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2007
First Posted
October 16, 2007
Study Start
April 1, 2005
Primary Completion
June 1, 2010
Study Completion
September 1, 2010
Last Updated
January 18, 2012
Record last verified: 2012-01